INVESTIGATOR AGREEMENTInvestigator Agreement • June 13th, 2016
Contract Type FiledJune 13th, 2016Title of Study: A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus